首页> 外文期刊>Biochimie >Effects of poly valency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galβ1-terminated core saccharides on the binding of domain-Ⅰ of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N
【24h】

Effects of poly valency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galβ1-terminated core saccharides on the binding of domain-Ⅰ of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N

机译:糖基多价和人血型ABH /刘易斯糖在Galβ1末端核心糖上的天然修饰对大鼠胃肠道(G4-N)重组串联重复型galectin-4结构域Ⅰ结合的影响

获取原文
获取原文并翻译 | 示例
       

摘要

In our recent publication, we defined core aspects of the carbohydrate specificity of domain-Ⅰ of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N), especially its potent interaction with the linear tetrasaccharide Galβ1-3GlcNAcβ1-3Galβ1-4Glc (I(β1-3L). The assumed role of galectin-4 as a microvillar raft stabilizer/organizer and as a malignancy-associated factor in hepatocellular and gastrointestinal carcinomas called for further refinement of its binding specificity. Thus, the effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the terminal Galβ1-core saccharides were thoroughly examined by the enzyme-linked lectinosorbent and lectin-glycan inhibition assays. The results indicate that (a) a high-density of polyvalent Galβ1-3/4GlcNAc (Ⅰ/Ⅱ), Galβ1-3GalNAc (T) and/or GalNAcα1-Ser/Thr (Tn) strongly favors G4-N/glycoform binding. These glycans were up to 2.3 x 10~6, 1.4 x 10~6, 8.8 x 10~5, and 1.4 x 10~5 more active than Gal, GalNAc, monomeric Ⅰ/ Ⅱ and T, respectively; (b) while LFuc is a poor inhibitor, its presence as α1-2 linked to terminal Galβ1-containing oligosaccharides, such as H active Iβ1-3L, markedly enhances the reactivities of these ligands; (c) when blood group A (GalNAcα1-) or B (Galα1-) determinants are attached to terminal Galβ1-3/4GlcNAc (or Glc) oligosaccharides, the reactivities are also increased; (d) with LFucα1-3/4 linked to sub-terminal GlcNAc, the reactivities of these haptens are reduced; and (e) short chain Le~a/Le~x/Le~y and the short chains of sialyl Le~a/Le~x are poor inhibitors. These distinct binding features of G4-N establish the important concept of affinity enhancement by high density polyvalencies of glycotopes (vs. multi-antennary Ⅰ/ Ⅱ) and by introduction of an ABH key sugar to Gal β1-terminated core glycotopes. The polyvalent ligand binding properties of G4-N may help our understanding of its crucial role for cell membrane raft stability and provide salient information for the optimal design of blocking substances such as anti-tumoral glycodendrimers.
机译:在我们最近的出版物中,我们定义了来自大鼠胃肠道(G4-N)的重组串联重复型galectin-4的结构域Ⅰ的碳水化合物特异性的核心方面,尤其是其与线性四糖Galβ1-3GlcNAcβ1-3Galβ1的有效相互作用。 -4Glc(I(β1-3L)。galectin-4在肝细胞和胃肠道癌中作为微绒筏稳定剂/组织剂和恶性肿瘤相关因子的假定作用要求进一步改善其结合特异性。通过酶联电凝集吸附剂和凝集素-聚糖抑制试验,彻底检查了糖基的多价和人类血型ABH /刘易斯糖在末端Galβ1核心糖上的天然修饰,结果表明:(a)高密度的多价Galβ1-3/ 4GlcNAc(Ⅰ/Ⅱ),Galβ1-3GalNAc(T)和/或GalNAcα1-Ser/ Thr(Tn)强烈支持G4-N /糖形式的结合,这些糖聚糖的最大吸附量为2.3 x 10〜6,1.4 x 10〜6、8.8 x 10〜5和1.4 x 10〜5 mo分别比Gal,GalNAc,单体Ⅰ/Ⅱ和T具有活性。 (b)虽然LFuc是一种弱抑制剂,但它以α1-2的形式存在于末端含Galβ1的寡糖(如H活性Iβ1-3L)上,显着增强了这些配体的反应性; (c)当将血型A(GalNAcα1-)或B(Galα1-)决定簇连接到末端Galβ1-3/ 4GlcNAc(或Glc)寡糖时,反应性也提高了; (d)LFucα1-3/ 4连接至亚末端GlcNAc,这些半抗原的反应性降低; (e)短链Lea / Lex / Ley和唾液酸Lea / Lex的短链是较弱的抑制剂。 G4-N的这些独特的结合特征通过高密度的糖基多价(相对于多天线Ⅰ/Ⅱ)以及通过将ABH关键糖引入Galβ1终止的核心糖基而建立了亲和力增强的重要概念。 G4-N的多价配体结合特性可能有助于我们了解其对细胞膜筏稳定性的关键作用,并为优化设计阻断性物质(例如抗肿瘤糖树状聚合物)提供重要信息。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号